Logo

Two Genomics Patents for Mass. General Hospital

Apr 08, 2000
Premium

R

OCKVILLE, Md.--Two functional genomics and drug discovery patents have been issued to Massachusetts General Hospital and exclusively licensed to Life Technologies here. The patents for the Reverse Two-Hybrid System cover methods and reagents for characterization of large-molecule interactions within organisms. The system is designed to help achieve understanding of cellular mechanisms for the development of more targeted and effective drugs, the company said.

Filed under

Informatics
Breaking News
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.